Skip to Main Content

The earlier detection of ovarian cancer using an mDETECT liquid biopsy

Using patient-derived models and drug sensitivity testing to guide personalized medicine: a proof-of-concept trial

ES2 trial: combining a PARP inhibitor and apoptosis sensitizer

Supercharging CAR-T cells for Ovarian Cancer

Building a scientific toolbox to study low-grade serous ovarian cancer

Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor

Understanding the experience of previvors receiving care at a specialized centre

Targeting epitranscriptomic mechanisms in ovarian cancer

Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor

Modelling low-grade serous cancer in 3D